Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.93 |
| ▸ | FDPS | P14324 | 15/20 | 0.47 |
| ▸ | PGK1 | P00558 | 1/20 | 0.45 |
| ▸ | PGK2 | P07205 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.35 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.33 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.33 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Etidronic Acid SCHEMBL1527591 | 1.00 | LMNA (0.93) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL41737 | 1.00 | LMNA (0.93) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL94632 | 1.00 | LMNA (0.93) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL17961664 | 1.00 | LMNA (0.93) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL7764099 | 1.00 | LMNA (0.93) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL4595371 | 1.00 | LMNA (0.93) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL10957057 | 0.97 | LMNA (0.87) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL6850113 | 0.97 | LMNA (0.87) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL10705565 | 0.97 | LMNA (0.87) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL18607 | 0.96 | LMNA (1.00) | LMNAFDPSPGK1PGK2CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1034 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250127699-A1 | One Pot Process for Preparing 'Grit-Free' Solid Cleansing Compositions | GALAXY SURFACTANTS LTD. (IN) | 2025-04-24 | — | — | US | claimed |
| EP-4541340-A1 | A ONE POT PROCESS FOR PREPARING 'GRIT-FREE' SOLID CLEANSING COMPOSITIONS | Galaxy Surfactants Ltd. (IN) | 2025-04-23 | — | — | EP | claimed |
| EP-3691450-B1 | QUATERNARY AMMONIUM ETIDRONATES | INNOVATIVE WATER CARE LLC (US) | 2024-08-21 | — | — | EP | claimed |
| CN-118480030-A | Cerebulin ligands and bifunctional compounds comprising same | 阿尔维纳斯运营股份有限公司 | 2024-08-13 | — | — | CN | claimed |
| CN-118340897-A | Composition for enhancing anti-tumor effect of heme response agent based on cell in-situ assembly and application | 无锡市南京大学锡山应用生物技术研究所 | 2024-07-16 | — | — | CN | claimed |
| CN-118267481-A | Construction and application of mRNA nano delivery system with environment adaptability and cooperative regulation | 浙江大学 | 2024-07-02 | — | — | CN | claimed |
| CN-118141982-A | Biodegradable and injectable adhesive bone cement for osteoporosis and preparation method and application thereof | 华东理工大学 | 2024-06-07 | — | — | CN | claimed |
| US-11971510-B2 | Gel dosimeter for measuring radiation dose | RIKEN (JP) | 2024-04-30 | — | — | US | claimed |
| US-11960038-B2 | Radiation dosimetry gel and radiation dosimeter comprising same as material for measuring radiation dose | RIKEN (JP) | 2024-04-16 | — | — | US | claimed |
| CN-117500507-A | Phosphorus derivatives as novel SOS1 inhibitors | 拜耳公司 | 2024-02-02 | — | — | CN | claimed |
| US-20070154559-A1 | Nanoparticle compositions of water-soluble drugs for oral administration and preparation methods thereof | SAMYANG BIOPHARMACEUTICALS CORPORATION (KR) | 2007-07-05 | — | — | US | claimed |
| EP-1696961-A1 | NANOPARTICLE COMPOSITIONS OF WATER-SOLUBLE DRUGS FOR ORAL ADMINISTRATION AND PREPARATION METHODS THEREOF | Samyang Corporation (KR) | 2006-09-06 | — | — | EP | claimed |
| WO-2005061004-A1 | NANOPARTICLE COMPOSITIONS OF WATER-SOLUBLE DRUGS FOR ORAL ADMINISTRATION AND PREPARATION METHODS THEREOF | SAMYANG CORPORATION (KR) | 2005-07-07 | — | — | WO | claimed |
| EP-1465606-A2 | DOSAGE FORM WITH A CORE TABLET OF ACTIVE INGREDIENT SHEATHED IN A COMPRESSED ANNULAR BODY OF POWDER OR GRANULAR MATERIAL, AND PROCESS AND TOOLING FOR PRODUCING IT | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2004-10-13 | — | — | EP | claimed |
| US-20030206954-A1 | Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it | LERNER E ITZHAK (IL) | 2003-11-06 | — | — | US | claimed |
| WO-2003057136-A2 | DOSAGE FORM WITH A CORE TABLET OF ACTIVE INGREDIENT SHEATHED IN A COMPRESSED ANNULAR BODY OF POWDER OR GRANULAR MATERIAL, AND PROCESS AND TOOLING FOR PRODUCING IT | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2003-07-17 | — | — | WO | claimed |
| EP-0364559-B1 | SUBSTITUTED ADENINE DERIVATIVES USEFUL AS THERAPEUTIC AGENTS | SCRIPPS RESEARCH INST (US) | 1995-09-20 | — | — | EP | claimed |
| EP-0364559-A4 | SUBSTITUTED ADENINE DERIVATIVES USEFUL AS THERAPEUTIC AGENTS | — | 1991-01-09 | — | — | EP | claimed |
| EP-0364559-A1 | SUBSTITUTED ADENINE DERIVATIVES USEFUL AS THERAPEUTIC AGENTS. | SCRIPPS CLINIC RES (US) | 1990-04-25 | — | — | EP | claimed |
| WO-1989008658-A1 | SUBSTITUTED ADENINE DERIVATIVES USEFUL AS THERAPEUTIC AGENTS | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1989-09-21 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250127699-A1 | One Pot Process for Preparing 'Grit-Free' Solid Cleansing Compositions | DEGS1, SGMS1, LIPA | LMNA 2325/4885FDPS 1809/4885PGK1 2050/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.